A global market leader, Covidien (formerly Tyco Healthcare) employs 41,000 people worldwide in more than 65 countries with products sold in over 140 countries and 48 manufacturing facilities in 17 countries. Dedicated to R&D, Covidien invested over $550 million in 2011, with projected increases in 2012 expected to continue to grow. Covidien is committed to creating innovative medical solutions for better patient outcomes and delivering value through clinical leadership and excellence. Website http://www.medtronic.com/covidien Introduction Managing rapid expansion efficiently. Global expansion over the years has seen Covidien grow it’s sites rapidly resulting in many individual offices each with local business operations including Sales, Distribution Centres, Manufacturing and Contact Ce

Join for free to read